| IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM (NCT04003649) | City of Hope Medical Center | 2019-12-02 |
| Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM (NCT03705351) | Providence Health & Services | 2019-12-02 |
| Humanized CAR-T Cells of Anti-BCAM and Anti-CD19 Against Relapsed and Refractory Multiple Myeloma (NCT04194931) | The First Affiliated Hospital of Nanchang University | 2019-12-01 |
| Safety and Efficacy of CD19-Targeted CAR-T Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma (NCT04271800) | Chongqing Precision Biotech Co., Ltd | 2019-12-01 |
| Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD) (NCT03645525) | Children's Hospital of Fudan University | 2019-12-01 |
| Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid Leukemia (NCT04272125) | Chongqing Precision Biotech Co., Ltd | 2019-12-01 |
| AlloGeneic Human Mesenchymal Stem Cells (hMSC) in PAtients With FistuLizing Crohn's Disease Via PErifistula iNjEctions (GALENE) (NCT02677350) | Joshua M Hare | 2019-12-01 |
| Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour (NCT04107142) | CytoMed Therapeutics Pte Ltd | 2019-12-01 |
| Comparison Between Two Drugs (Propofol and Nitroglycerin as a Hypotensive Agents During Endoscopic Sinus Surgery (NCT04220281) | Ain Shams University | 2019-12-01 |
| Cryoablation Combined With Camrelizumab and Apatinib for Multiprimary Lung Cancer (NCT04201990) | ShiYue Li | 2019-12-01 |
| Gallium-68 Labeled LM3 PET/CT in Neuroendocrine Tumors (NCT04318561) | Peking Union Medical College Hospital | 2019-12-01 |
| CTA101 in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (NCT04026100) | The First Affiliated Hospital with Nanjing Medical University | 2019-12-01 |
| Safety and Efficacy of BCMA-Targeted CAR-T Therapy for Relapsed/Refractory Multiple Myeloma (NCT04272151) | Chongqing Precision Biotech Co., Ltd | 2019-12-01 |
| Safety, Tolerability and PK/PD Evaluation of Intravenous Administration of MRT5201 in Patients With OTC Deficiency (NCT03767270) | Translate Bio, Inc. | 2019-12-01 |
| Clinical Study of Granulocyte Infusion for Advanced Cancer (NCT04124666) | Shanghai East Hospital | 2019-12-01 |
| Open-label Multicenter Phase 1 Study of TBI 302 as Second-Line Therapy in Patients With Hepatocellular Carcinoma (NCT03908840) | Evolve Biologics | 2019-12-01 |
| PDT Plus Vitamin D3 for Anal Dysplasia (NCT02698293) | Abramson Cancer Center at Penn Medicine | 2019-12-01 |
| Capsaicin for Cerebral Perfusion Augmentation. (NCT04545892) | Juan Manuel Marquez Romero | 2019-12-01 |
| The Safety and Feasibility of Transoral Endoscopic Thyroidectomy Vestibular Approach (NCT04842942) | University Health Network, Toronto | 2019-12-01 |
| A Safety and Efficacy Study of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Critical Limb Ischemia (NCT02477540) | Pharmicell Co., Ltd. | 2019-12-01 |
| Pharmacokinetic Interaction and Safety/Tolerability Between NVP-1603-1 and NVP-1603-2 (NCT03220399) | NVP Healthcare | 2019-12-01 |
| Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells (GXCPC1) for Knee Osteoarthritis (NCT03943576) | Gwo Xi Stem Cell Applied Technology Co., Ltd. | 2019-12-01 |
| A Safety and Tolerability Study of GB301 (NCT03865017) | VTBIO Co. LTD | 2019-12-01 |
| Sorafenib Plus Toripalimab for Unresectable HCC With Portal Vein Tumor Thrombus (NCT04069949) | Sichuan University | 2019-12-01 |
| A Study of Toca 511 & Toca FC in Patients With Recurrent High Grade Non-Muscle Invasive Bladder Cancer (Toca 8) (NCT04089163) | Tocagen Inc. | 2019-12-01 |
| Behavioral and Physiological Effects of THC and CBD (NCT03832816) | Johns Hopkins University | 2019-12-01 |
| Evaluating Combination Therapy Using Autologous Dendritic Cells Pulsed With Antigen Peptides and Nivolumab for Subjects With Advanced Non-Small Cell Lung Cancer (NCT04199559) | Henan Cancer Hospital | 2019-12-01 |
| Safety of Autologous Humanized Anti-CD19 and Anti-CD20 Dual Specific CAR-T Cells in Adult Patients With Diffuse Large B-cell Lymphoma (NCT04215016) | Fujian Medical University | 2019-12-01 |
| Safety and Efficacy of γδ T Cell Against Gastric Cancer (NCT02585908) | Beijing Doing Biomedical Co., Ltd. | 2019-12-01 |
| Does rTMS Induce Synaptic Plasticity? (NCT04311619) | Davidzon, Guido, M.D. | 2019-12-01 |
| Anti-CD19 CAR-T Cells for Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphomas (NCT04196205) | The First Affiliated Hospital of Nanchang University | 2019-12-01 |
| Evaluation of the Effect of a Combination of Plant Extracts (BSL_EP027) on the Incidence of Respiratory Infections (NCT04386408) | Biosearch S.A. | 2019-11-30 |
| A Study of LY900020 in Healthy Chinese Participants (NCT04047940) | Eli Lilly and Company | 2019-11-29 |
| A Study of the Safety, Tolerability and Pharmacokinetics of MEDI0618 in Healthy Volunteers (NCT04198558) | AstraZeneca | 2019-11-29 |
| Study of Guselkumab and Ustekinumab Following a Single Intravenous or Subcutaneous Administration in Healthy Chinese Participants (NCT04030533) | Janssen Research & Development, LLC | 2019-11-29 |
| Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML (NCT03825367) | Therapeutic Advances in Childhood Leukemia Consortium | 2019-11-29 |
| Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary Sclerosis (NCT03540485) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2019-11-29 |
| Study to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial Pneumonia (NCT04160260) | Paratek Pharmaceuticals Inc | 2019-11-28 |
| A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation (NCT04165031) | Eli Lilly and Company | 2019-11-28 |
| A Clinical Trial to Evaluate the Safety and Immunogenicity of Norovirus Bivalent Vaccine (NCT04188691) | National Vaccine and Serum Institute, China | 2019-11-28 |
| A Clinical Study to Test the Safety, Exposure, and Pharmacodynamic Markers of CSL311 in Patients With Mild-to-moderate Asthma and in Healthy Volunteers (NCT04082754) | CSL Behring | 2019-11-28 |
| MAX-40279-01 in Patients With Advanced Solid Tumors (NCT04183764) | Maxinovel Pty., Ltd. | 2019-11-28 |
| MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL) (NCT04110301) | Beijing Mabworks Biotech Co., Ltd. | 2019-11-28 |
| ADR-002K for Patients With Ischemic Cardiomyopathy Who Undergo Coronary Artery Bypass Surgery (NCT04695522) | Osaka University | 2019-11-27 |
| COPD Treatment by Transplantation of Autologous Bronchial Basal Cells (NCT05594303) | Guangzhou Institute of Respiratory Disease | 2019-11-27 |
| Treatment of Heart Failure Using Human Umbilical Cord Mesenchymal Stem Cells(hUC-MSC) (NCT04939077) | Shanghai East Hospital | 2019-11-27 |
| A Phase Ia/Ib Study of IBI315 in Patients With HER2-expressing Advanced Solid Tumor (NCT04162327) | Innovent Biologics (Suzhou) Co. Ltd. | 2019-11-26 |
| A Study of LY3471851 in Participants With Psoriasis (NCT04119557) | Nektar Therapeutics | 2019-11-26 |
| A Study to Test Different Doses of BI 891065 Alone and in Combination With BI 754091 in Asian Patients With Different Types of Advanced Cancer (Solid Tumours) (NCT04138823) | Boehringer Ingelheim | 2019-11-26 |
| Evaluation of Safety and Efficacy of KPG-121 Plus Enzalutamide, Abiraterone or Apalutamide in CRPC Patients (NCT03569280) | Kangpu Biopharmaceuticals, Ltd. | 2019-11-26 |
| Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Feladilimab (GSK3359609) in Participants With RRMM (NCT07217119) | GlaxoSmithKline | 2019-11-26 |
| Safety and Tolerability Ultra-high-caloric Food Supplements in Amyotrophic Lateral Sclerosis (ALS) (NCT04172792) | Albert Christian Ludolph, Prof. | 2019-11-26 |
| First in Human Study: LIS1, an Induction Treatment in Kidney Transplanted Patients (NCT04431219) | Xenothera SAS | 2019-11-26 |
| Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer (NCT04324307) | Changhai Hospital | 2019-11-26 |
| Single-dose Study to Investigate the Plasma PK of KW-6356 and Its Major Metabolite (NCT04190654) | Kyowa Kirin, Inc. | 2019-11-26 |
| A Study to Learn How the Study Treatment BAY1753011 Moves Into, Through and Out of the Body, How it Works, How Safe it is, and How it Affects the Body When Given Once as Tablet in Male and Female Participants With Reduced Kidney Function Compared to Matched Participants With Normal Kidney Function (NCT05599997) | Bayer | 2019-11-25 |
| Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02 (NCT04167696) | Celyad Oncology SA | 2019-11-25 |
| A Research Study Looking at Similarity Between Once-weekly Semaglutide Versions for Different Injection Pens (NCT04152915) | Novo Nordisk A/S | 2019-11-25 |
| Safety and Efficacy of Radiotherapy Plus Sintilimab for HCC With Portal Vein Tumor Thrombosis (NCT04104074) | Beijing Tsinghua Chang Gung Hospital | 2019-11-25 |
| Phase 1/2 Study of OBI-999 in Patients With Advanced Solid Tumors (NCT04084366) | OBI Pharma, Inc | 2019-11-25 |
| A Study to Examine the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy Subjects (NCT04183686) | Idorsia Pharmaceuticals Ltd. | 2019-11-25 |
| Randomized, Double Blinded, Placebo Controlled, Single Dose Escalation Study of 608 in Healthy Subjects (NCT04367441) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2019-11-25 |
| Study of NMS-03305293 in Pts with Selected Advanced/Metastatic Solid Tumors (NCT04182516) | Nerviano Medical Sciences | 2019-11-25 |
| Ovarian Cancer Treatment With a Liposome Formulated mRNA Vaccine in Combination With (Neo-)Adjuvant Chemotherapy (NCT04163094) | University Medical Center Groningen | 2019-11-25 |
| A Phase I, Open-Label Trial to Assess the Absorption, Metabolism, and Excretion of (14C)-OPC-61815 in Healthy Male Japanese Subjects (NCT04182958) | Otsuka Pharmaceutical Co., Ltd. | 2019-11-25 |
| Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG Treatment (NCT04179162) | Memorial Sloan Kettering Cancer Center | 2019-11-22 |
| Single Ascending Dose and Multiple Ascending Dose Study of Voriconazole Inhalation Powder in Healthy Adult Subjects (NCT04872231) | TFF Pharmaceuticals, Inc. | 2019-11-22 |
| A Safety, Tolerability, and Pharmacokinetic Study of NIP292 in Healthy Normal Subjects (NCT04720443) | The National Institutes of Pharmaceutical R&D Co. Ltd, China | 2019-11-22 |
| A Phase 1 Trial of OPB-111077 in Combination With Bendamustine and Rituximab in Patients With r/r DLBCL (NCT04049825) | Otsuka Pharmaceutical Co., Ltd. | 2019-11-22 |
| A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer (NCT04227275) | Tceleron Therapeutics, Inc. | 2019-11-22 |
| Extracorporeal Photopheresis of Patients With Crohn's Disease Using 5-aminolevulinic Acid (NCT04164849) | University Hospital, Akershus | 2019-11-22 |
| Study of Anlotinib Plus Chemoradiotherapy in Patients With Locally Advanced NSCLC (NCT04182698) | Second Affiliated Hospital of Xi'an Jiaotong University | 2019-11-22 |
| Elafibranor Pharmacokinetic Parameters in Elderly Healthy Volunteers (NCT04171752) | Genfit | 2019-11-22 |
| Study to Evaluate the Effect of SCY-078 (Ibrexafungerp) on the PK of Pravastatin in Healthy Subjects (NCT04092751) | Scynexis, Inc. | 2019-11-22 |
| Trial Evaluating the Clinical Efficacy of Cefixime for Treatment of Early Syphilis in Non-pregnant Women (NCT03752112) | World Health Organization | 2019-11-22 |
| A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast Cancer (NCT04060862) | Hoffmann-La Roche | 2019-11-21 |
| Study of TAK-925 in Participants With Obstructive Sleep Apnea (OSA) Who Are Experiencing Excessive Daytime Sleepiness (EDS) Despite Adequate Use of Continuous Positive Airway Pressure (CPAP) (NCT04091425) | Millennium Pharmaceuticals, Inc. | 2019-11-21 |
| Testing the Combination of the Anti-cancer Drugs Copanlisib, Olaparib, and MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumors With Selected Mutations (NCT03842228) | National Cancer Institute (NCI) | 2019-11-21 |
| Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies (NCT04013685) | Orca Biosystems, Inc. | 2019-11-21 |
| A Study to Determine Safety and Tolerability of GMI-1359 in Subjects With HR+ Metastatic Breast Cancer (NCT04197999) | GlycoMimetics Incorporated | 2019-11-21 |
| To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD8233 After Multiple Dose Administration in Subjects With Dyslipidemia (NCT04155645) | AstraZeneca | 2019-11-21 |
| Study of Single-dose DS-3201b in Participants With Hepatic Impairment (NCT04276662) | Daiichi Sankyo | 2019-11-21 |
| BDB001-102: Open Label Dose Escalation of BDB001 in Combination w Atezolizumab (NCT04196530) | Eikon Therapeutics | 2019-11-21 |
| Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors (NCT04116320) | Craig L Slingluff, Jr | 2019-11-21 |
| Study Evaluating Safety and Efficacy of UCART Targeting CS1 in Patients With Relapsed/Refractory Multiple Myeloma (MELANI-01) (NCT04142619) | Cellectis S.A. | 2019-11-21 |
| Safety, Tolerability and Pharmacokinetics Characteristics of Recombinant Oncolytic Vaccinia Virus Injection T601 as a Single Drug or in Combination With Oral Flucytosine (5-FC), in Patients With Advanced Malignant Solid Tumors (NCT04226066) | Tasly Tianjin Biopharmaceutical Co., Ltd. | 2019-11-20 |
| AB-1002 in Patients With Class III Heart Failure (NCT04179643) | AskBio Inc | 2019-11-20 |
| To Evaluate the Effect of Food on the Pharmacokinetic Characteristics of Alkotinib Capsules in Healthy Subjects (NCT04032821) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2019-11-20 |
| Higher Doses of Botulinum Toxin in the Treatment of Gummy Smile (NCT05127018) | Peking University | 2019-11-20 |
| Generation of Biological Samples Positive to Hydromorphone for Anti-doping Control (NCT04081376) | Parc de Salut Mar | 2019-11-20 |
| A Study of Galcanezumab (LY2951742) in Healthy Chinese Participants (NCT04085289) | Eli Lilly and Company | 2019-11-20 |
| Phase 1 to Evaluate the Safety and Pharmacokinetic Durg-drug Interaction of YYC506-T and YYC506-A (NCT04874142) | Yooyoung Pharmaceutical Co., Ltd. | 2019-11-20 |
| Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Pleural Effusions (NCT03869697) | Clover Biopharmaceuticals AUS Pty | 2019-11-20 |
| A Biomarker-directed Study of XPro1595 in Patients With Alzheimer's (NCT03943264) | Inmune Bio, Inc. | 2019-11-20 |
| E-CEL UVEC Cells as an Adjunct Cell Therapy for the Arthroscopic Rotator Cuff Repair in Adults (NCT04057833) | Hospital for Special Surgery, New York | 2019-11-20 |
| A Study of LY3556050 in Healthy Participants (NCT04156750) | Eli Lilly and Company | 2019-11-20 |
| Olaparib for PAH: a Multicenter Clinical Trial (NCT03782818) | Laval University | 2019-11-20 |
| Effect of Ketamine Intranasal Spray in Treatment of Chronic Cluster Headache (NCT04179266) | CCH Pharmaceuticals | 2019-11-20 |
| A Safety Study of LY3462817 and LY3509754 in Participants With Psoriasis (NCT04152382) | Eli Lilly and Company | 2019-11-20 |
| Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors. (NCT04171141) | Pfizer | 2019-11-19 |